Anticonvulsant Medications in PI Cases: Attorney Overview

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 26, 2026 | 7 min read

Anticonvulsant medications — gabapentin, pregabalin, topiramate, and carbamazepine — are among the most frequently prescribed drugs in personal injury cases, primarily for off-label pain management rather than seizure control. Understanding why these drugs appear on pharmacy liens strengthens demand packages.

Anticonvulsant Medications in PI Cases: Attorney Overview

Anticonvulsant medications are drugs originally developed to treat epilepsy and seizure disorders that have become standard-of-care treatments for neuropathic pain, post-traumatic migraine, and nerve injury — conditions that commonly result from personal injury accidents. When these medications appear on a pharmacy lien, they document specific neurological injury that supports higher settlement values.

• Gabapentin and pregabalin treat neuropathic pain from nerve compression, radiculopathy, and disc herniation
• Topiramate is prescribed for post-traumatic migraine prevention after head and cervical injuries
• Carbamazepine treats trigeminal neuralgia and specific nerve injury pain syndromes
• Off-label use for pain is well-established and supported by clinical guidelines
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

Why Anticonvulsants Appear on PI Pharmacy Liens

Personal injury accidents frequently cause nerve damage — herniated discs compressing nerve roots, traumatic neuropathy from crush injuries, post-traumatic migraine from cervical or head trauma. These neurological conditions produce pain that standard analgesics (NSAIDs, acetaminophen) cannot adequately control.

Anticonvulsants work by stabilizing overactive nerve signals. The same mechanism that prevents seizures — calming excessive electrical activity in neurons — also calms the misfiring pain signals produced by damaged nerves. This is why neurologists and pain management physicians prescribe these "seizure drugs" for patients who have never had a seizure.

[!KEY] When an adjuster questions why a PI patient is taking "seizure medication," the answer is straightforward: anticonvulsants are standard-of-care treatment for neuropathic pain, and their presence on the medication list documents nerve injury that standard pain relievers cannot address.

Gabapentin: The Most Common Anticonvulsant in PI Cases

Generic name: Gabapentin Brand names: Neurontin, Gralise PI indications: Neuropathic pain, radiculopathy, post-surgical nerve pain, post-herpetic neuralgia exacerbated by trauma

Gabapentin is the most frequently prescribed anticonvulsant in personal injury pharmacy liens. It works by binding to calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters that transmit pain signals.

Why it matters for demand packages: A gabapentin prescription documents that the treating physician identified neuropathic pain — pain originating from nerve damage rather than simple tissue inflammation. This diagnosis implies a more serious injury than soft tissue alone.

Dosing pattern: Gabapentin is typically started at 300mg daily and titrated up to 1800-3600mg daily in divided doses. A dosing escalation over time documents worsening or persistent nerve pain.

According to James Wong, PharmD, founder of LienScripts, "When we see gabapentin titrated from 300mg to 2400mg over several months, that prescription history tells a clinical story — the nerve injury is significant enough to require progressively higher doses. That trajectory is powerful evidence of injury severity."

Pregabalin: Gabapentin's More Potent Relative

Generic name: Pregabalin Brand name: Lyrica PI indications: Neuropathic pain, fibromyalgia (post-traumatic), nerve injury pain

Pregabalin works through the same mechanism as gabapentin but with higher potency and more predictable absorption. It is typically prescribed when gabapentin provides inadequate relief or produces intolerable side effects at required doses.

Why it matters for demand packages: An escalation from gabapentin to pregabalin documents treatment failure at a lower-potency drug — evidence that the neuropathic pain is severe enough to require a stronger medication.

[!TIP] When a patient's medication history shows a switch from gabapentin to pregabalin, highlight this escalation in the demand package. Treatment escalation is objective evidence that the injury is not resolving with standard therapy and requires more aggressive intervention.

Topiramate: Post-Traumatic Migraine Prevention

Generic name: Topiramate Brand names: Topamax, Qudexy XR, Trokendi XR PI indications: Post-traumatic migraine prevention, post-concussion headache

Topiramate is FDA-approved for migraine prevention and is commonly prescribed after traumatic brain injuries, concussions, and cervical whiplash injuries that trigger chronic migraine patterns. It works through multiple mechanisms — sodium channel blockade, GABA enhancement, and glutamate inhibition.

Why it matters for demand packages: Topiramate for migraine prevention documents ongoing post-traumatic headache that is severe and frequent enough to require daily preventive medication. This is qualitatively different from occasional headaches treated with OTC pain relievers.

Carbamazepine: Specific Nerve Injury Pain

Generic name: Carbamazepine Brand names: Tegretol, Carbatrol PI indications: Trigeminal neuralgia, specific cranial and peripheral nerve injury pain

Carbamazepine is the gold standard treatment for trigeminal neuralgia — severe, lancinating facial pain caused by nerve injury or compression. In PI cases, it documents specific nerve damage, particularly in facial, jaw, or skull base injuries.

Why it matters for demand packages: Carbamazepine is prescribed for very specific nerve injury syndromes. Its presence on a medication list is highly diagnostic — it tells the adjuster exactly what type of nerve damage occurred.

Off-Label Use: Why Adjusters Challenge and Why They're Wrong

Insurance adjusters sometimes challenge anticonvulsant prescriptions because the FDA-approved indication is seizure disorder, not pain. This challenge misunderstands how pharmaceutical regulation works.

Off-label prescribing is legal and standard. Physicians are legally permitted to prescribe any FDA-approved drug for any condition based on their clinical judgment. Off-label use accounts for approximately 20% of all prescriptions in the United States.

Clinical guidelines support these uses. The American Academy of Neurology, the International Association for the Study of Pain, and multiple other professional organizations include gabapentin and pregabalin in their treatment guidelines for neuropathic pain.

[!KEY] Off-label prescribing of anticonvulsants for pain is not experimental or inappropriate — it is standard of care supported by decades of clinical evidence and endorsed by major medical organizations. Adjusters who challenge these prescriptions are challenging established medical practice.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Every anticonvulsant on a LienScripts pharmacy lien includes a MERIT narrative explaining the off-label indication, the clinical rationale, and the evidence base. This preempts the 'it's a seizure drug' objection before it's raised."

The Evidentiary Value of Anticonvulsants in Demand Packages

Anticonvulsant prescriptions support settlement value in several ways:

1. They document nerve injury. Nerve damage is a more serious diagnosis than soft tissue inflammation alone.
2. Dosing escalation shows severity progression. Increasing doses over time document worsening or persistent neurological symptoms.
3. Drug switches document treatment complexity. Moving from gabapentin to pregabalin shows the injury required more aggressive intervention.
4. Long-term prescriptions document chronicity. Anticonvulsants prescribed for months or years demonstrate that the neurological injury has become chronic.
5. Side effect management documents treatment burden. Anticonvulsants cause drowsiness, cognitive effects, and weight changes that impact quality of life.

Contact LienScripts to learn how MERIT documentation explains anticonvulsant prescriptions in your PI cases.

Related Resources

• Gabapentin for Whiplash-Related Nerve Pain
• Pain Management After a Car Accident
• How to Use Pharmacy Records in Your Demand Package